CheckMyRecalls

Acella Pharmaceuticals, LLC recalls NAPROXEN ORAL SUSPENSION

Published
13 May 2026
Units affected
6,336 bottles
Agency
FDA
Country
United States

The hazard

Chemical contamination; presence of lead and lithium above specification

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, Made in Canada NDC 42192-619-16

Brand / company
Acella Pharmaceuticals, LLC
Codes / lots
Lot: 23F02, Expires: 05/2026; 25A37, Expires: 01/2028.
Distribution
Nationwide
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 13 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.